Exploring the role of circulating proteins in multiple myeloma risk: a Mendelian randomization study

Exploring the role of circulating proteins in multiple myeloma risk: a Mendelian randomization study

Abstract Multiple myeloma (MM) is an incurable blood cancer with unclear aetiology. Proteomics is a valuable tool in exploring mechanisms of disease. We investigated the causal relationship between circulating proteins and MM risk, using two of the largest cohorts with proteomics data to-date. We pe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Matthew A. Lee, Kate L. Burley, Emma L. Hazelwood, Sally Moore, Sarah J. Lewis, Lucy J. Goudswaard
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-01-01
Series:	Scientific Reports
Subjects:	Proteomics Multiple myeloma Mendelian randomization Genetic colocalization
Online Access:	https://doi.org/10.1038/s41598-025-86222-5
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Unveiling causal immune cell–gene associations in multiple myeloma: insights from systematic reviews and Mendelian randomization analyses
by: Hui Zhang, et al.
Published: (2025-01-01)

Causal associations between osteoporosis and HBV infection across Asian and European populations: evidence from Mendelian randomization and colocalization analysis
by: Zhengnan Li, et al.
Published: (2025-01-01)

Identification of therapeutic target genes for age-related hearing loss through systematic genome-wide mendelian randomization of druggable genes
by: Kun Zhang, et al.
Published: (2025-02-01)

Identification of biomarkers for chronic lymphocytic leukemia risk: a proteome-wide Mendelian randomization study
by: Changyu Jin, et al.
Published: (2025-01-01)

Assessing inflammatory protein factors in inflammatory bowel Disease using multivariable mendelian randomization
by: Qiang Su, et al.
Published: (2025-01-01)

Association between red blood cell distribution width and genetic risk in patients with rheumatoid arthritis: a prospective cohort study and Mendelian randomization analysis
by: Mingyang Chen, et al.
Published: (2025-01-01)

Illuminating the Shadows: Innovation in Advanced Imaging Techniques for Myeloma Precursor Conditions
by: Kara I. Cicero, et al.
Published: (2025-01-01)

Insights Into Causal Effects of Genetically Proxied Lipids and Lipid‐Modifying Drug Targets on Cardiometabolic Diseases
by: Liwan Fu, et al.
Published: (2025-02-01)

Oral manifestations of multiple myeloma – A systematic review
by: Padmajaa Krishnan, et al.
Published: (2024-06-01)

Chromothripsis in Treatment Resistance in Multiple Myeloma
by: Kyoung Joo Lee, et al.
Published: (2017-09-01)

Proteome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Abdominal Aortic Aneurysm
by: Ka Zhang, et al.
Published: (2025-02-01)

Is There a Role for Daratumumab Retreatment in Patients with Relapsed/Refractory Multiple Myeloma?
by: Davor Galusic, et al.
Published: (2025-01-01)

Genetic and Plasma Proteomic Approaches to Identify Therapeutic Targets for Graves’ Disease and Graves’ Ophthalmopathy
by: Ke C, et al.
Published: (2025-02-01)

Use of disease modifying anti-rheumatic drugs and risk of multiple myeloma in US Veterans with rheumatoid arthritis
by: Kate Tokareva, et al.
Published: (2025-01-01)

Interconnections between BDH1-plasma protein-type 2 diabetes Mellitus: a mediated mendelian randomization analysis using plasma proteomics
by: Yi-Ying Liu, et al.
Published: (2025-01-01)

Rapid Progression of Plasmacytoma to Multiple Myeloma after Cervical Laminectomy
by: Dudung Lupito, et al.
Published: (2024-12-01)

Detection of new single nucleotide polymorphisms in plasma cells carcinoma (myeloma) by polymerase chain reaction–single strand conformation polymorphism and sequencing technical methods
by: Sarah K. Obayes, et al.
Published: (2024-01-01)

Rheumatoid Arthritis, Circulating Inflammatory Proteins, and Hypertension: A Mendelian Randomization Study
by: Guobing Jia, et al.
Published: (2025-01-01)

Genetic Biomarkers and Circulating White Blood Cells in Osteoarthritis: A Bioinformatics and Mendelian Randomization Analysis
by: Yimin Pan, et al.
Published: (2025-01-01)

Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
by: Memon H, et al.
Published: (2025-01-01)

A Nomogram Based on Circulating Inflammatory Factors for Predicting Prognosis of Newly Diagnosed Multiple Myeloma Patients
by: Wang M, et al.
Published: (2025-02-01)

Clinical Outcomes of Patients with Multiple Myeloma Presenting with Renal Failure
by: Joydeep Singh Vasant, et al.

The effect of cheese intake on osteoarthritis: a Mendelian randomization study
by: Song Wen, et al.
Published: (2024-12-01)

Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ/Parkin axis
by: Xuejie Gao, et al.
Published: (2025-01-01)

Prognostic correlation analysis of multiple myeloma based on HALP score of peripheral blood before chemotherapy
by: CHEN Min, et al.
Published: (2025-01-01)

Boanmycin overcomes bortezomib resistance by inducing DNA damage and endoplasmic reticulum functional impairment in multiple myeloma
by: Jin-Xing Wang, et al.
Published: (2025-01-01)

Diabetes and tuberculosis: a systematic review and meta-analyis of mendelian randomization evidence
by: Ivaan Pitua, et al.
Published: (2025-02-01)

Metformin and the risk of malignant tumors of digestive system: a mendelian randomization study
by: Ping Liu, et al.
Published: (2025-01-01)

Bidirectional causal associations between frailty measures and sleep disturbances: a two-sample Mendelian randomization study
by: Che L, et al.
Published: (2025-02-01)

Causal association between circulating α-Klotho levels and venous thromboembolism: a two-sample Mendelian randomization study
by: Yanmin Song, et al.
Published: (2025-01-01)

The association between the dietary inflammatory index and multiple myeloma: a case–control study
by: Hoda Zahedi, et al.
Published: (2025-01-01)

Metabolomics approach reveals key plasma biomarkers in multiple myeloma for diagnosis, staging, and prognosis
by: Xiaoxue Wang, et al.
Published: (2025-02-01)

Risk of infections in bispecific antibody therapy for multiple myeloma: a comprehensive review of literature
by: Fahad Alshammari, et al.
Published: (2025-12-01)

Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation
by: Jessy Sirera, et al.
Published: (2024-12-01)

Trace elements selenium and potassium are protective factors for cutaneous malignant melanoma: A Mendelian randomization study
by: Chen-Yu Li, et al.
Published: (2025-02-01)

Tandem Versus Single Autologous Stem Cell Transplantation for High‐Risk Multiple Myeloma in the Era of Novel Agents: A Real‐World Study of China
by: Xuelin Dou, et al.
Published: (2025-01-01)

Evaluation of plasma cell sorting methods in multiple myeloma patients: flow cytometry versus magnetic beads
by: Yu Jeong Choi, et al.
Published: (2025-01-01)

Bortezomib, thalidomide, and dexamethasone versus thalidomide and dexamethasone for response rates in multiple myeloma patients: a retrospective study
by: Juan M. Cano-Calderón, et al.
Published: (2025-01-01)

Sensorineural Hearing Loss as a First Presentation of Multiple Myeloma: A Successful Management with Therapeutic Plasma Exchange
by: Morteza Daraei, et al.
Published: (2024-12-01)

Multidimensional Plasma Lipids Affect Preeclampsia/Eclampsia: A Mendelian Randomization Study
by: Shaole Shi, et al.
Published: (2025-01-01)